Page 2 - Cervical Cancer

Poonam Pandey alive, appears in cervical cancer awareness video on Insta

Poonam Pandey on Saturday made an appearance on social media and said she is "alive", a day after there were reports that the actor had died of cervical cancer. "I feel compelled to share something significant with you all - I am here, alive. Cervical Cancer didn't claim me, but tragically, it has claimed the lives of thousands of women who stemmed from a lack of knowledge on how to tackle this disease," the 32-year-old actor posted on Instagram alongside a video. Pandey said she wants to spread "critical awareness" about the disease and ensure every woman is informed about the steps to take. "Together, let's strive to put an end to the devastating impact of the disease and bring #DeathToCervicalCancer," she wrote. On Friday, the actor's team made the shock announcement that Pandey passed away after a battle with cervical cancer but there was no confirmation of the death of the model, influencer and sometime actor known for her bold statements and appearances.

India registered 1.41 mn new cancer cases, 910,000 deaths in 2022: WHO

In 2022, India had more than 14.1 lakh new cancer cases and over 9.1 lakh deaths due to the disease, and breast cancer was the most common, according to the latest estimates of the disease's global burden by the World Health Organization (WHO). Cancers of lip, oral cavity and lung were the most common ones in men, accounting for 15.6 and 8.5 per cent of the new cases, respectively, whereas, cancers of breast and cervix uteri were the most frequent ones in women, making up close to 27 and 18 per cent of the new cases, the International Agency for Research on Cancer (IARC), WHO's cancer agency has estimated. It also calculated that the number of people alive within 5 years following a cancer diagnosis was nearly 32.6 lakhs in India. Globally, the agency estimated 2 crore new cancer cases and 97 lakh deaths, and about 5.3 crore people were alive within 5 years following a cancer diagnosis. About 1 in 5 people develop cancer in their lifetime, and roughly 1 in 9 men and 1 in 12 women di

'Lock Upp' fame Poonam Pandey dies of cervical cancer, says her manager

Actor and model Poonam Pandey passed away on Friday at the age of 32 due to cervical cancer, according to her media manager

Interim Budget: Over 3 mn ASHA, anganwadi workers now in Ayushman Bharat

Push to include cervical cancer vaccination in Universal Immunisation Programme and set up more medical colleges

Budget 2024: Govt will encourage vaccination for cervical cancer, says FM

As per 2022 estimates, every year, approximately 125,000 women are diagnosed with cervical cancer, and over 75 thousand die from the disease

Cervical cancer mortality rates drop, but experts stress need for vaccine

Experts anticipate indigenous vaccine to help curb cases, health ministry yet to take a decision on roll-out

From Daughter to Mother: Prioritising Women's Health on International Women's Day

To mark International Women's Day, Business Standard consulted Dr Asha Dalal, director, obstetrics & gynaecology at Sir HN Reliance Foundation Hospital about the crucial screening tests that women should undergo during various biological stages of their lives. Watch the video to know more

Vaccination of girls against cervical cancer can begin in 6 states in June

The government is likely to begin administering anti-cervical cancer vaccine in girls aged nine to 14 years in six states in June, official sources said on Sunday. In the first phase of the vaccination campaign, 2.55 crore girls are targeted to be administered the human papillomavirus (HPV) vaccine in Karnataka, Tamil Nadu, Mizoram, Chhattisgarh, Maharashtra and Uttar Pradesh, an official source told PTI. The Union Health Ministry has drawn a roadmap to roll out HPV vaccine in the universal immunisation programme and is likely to float a global tender in April for 16.02 crore doses to be procured by 2026, official sources said. The Serum Institute's made-in-India vaccine against cervical cancer, CERVAVAC, was launched last month. Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), has written a letter to the Health Ministry its first indigenous HPV vaccine will be available in the private market at an MRP of Rs 2,000 per dose, i

Production of vaccine against cervical cancer to be boosted: Poonawalla

A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year and its production will be boosted next year to take care of the needs of the nation. Speaking on the sidelines of an event after presenting the vaccine to Union Health Minister Mansukh Mandaviya, Poonawalla said the vaccine 'CERVAVAC' will be made available through the government programme this year. The vaccine for 9-14-year-old was launched on Tuesday in the presence of Union Home Minister Amit Shah, Poonawalla, and Director of Government and Regulatory Affairs at Serum Institute of India, Prakash K Singh. It will be available at a much lower price than the internationally branded vaccines available in the market, Singh had said earlier. The vaccine will be included in the National Immunisation Programme by mid-2023, government officials had said.

India sees most number of cervical cancer cases, deaths in Asia: Lancet

Lancet report titled, "Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative," highlights glaring reality

Vaccine against cervical cancer to be included by mid-2023: NTAGI chief

India would be in a position to roll out the indigenously developed Human Papillomavirus Vaccine (HPV) against cervical cancer for girls in the age group of 914 under the National Immunisation Programme by mid-2023, NTAGI chairperson Dr N K Arora said. The CERVAVAC vaccine is likely to be launched by the Serum Institute of India (SII) in April next year and will be available at a much lower price than the international vaccines available in the market, Prakash Kumar Singh, Director, Government and Regulatory Affairs at the SII said on the sidelines of the South Asia meeting on HPV here. The vaccine has received the DCGI's approval and been cleared by the government advisory panel National Technical Advisory Group on Immunisation (NTAGI) for use in the public health programme, Dr Arora told PTI. At present, the country is fully dependent on foreign manufacturers for the vaccine. Three foreign companies manufacture the HPV vaccine out of which two firms sell their vaccines in India. .

Cervical cancer fourth most common among women, says WHO official

Dr Singh said that WHO has called for action in several key areas to achieve the elimination target of four or less cases per 100,000 women

National Immunisation Mission: How indigenous vaccines can go a long way

The locally developed Ceravac can play a critical role in the efficacy of the National Immunisation Mission

India-made cervical cancer vaccine Ceravac to cost Rs 200-400 per dose

Serum India's product made in collaboration with state-run biotechnology department, expected to bring down prices

First indigenous vaccine for cervical cancer prevention to be out tomorrow

India's first indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for the prevention of cervical cancer will be launched here on Thursday, officials said on Wednesday The Drugs Controller General of India (DCGI) had last month granted market authorisation to Serum Institute of India (SII) to manufacture an indigenously-developed vaccine against cervical cancer. Union Minister of Science and Technology Jitendra Singh will launch the vaccine at IIC Delhi. SII CEO Adar Poonawalla will be present at the event, the officials said. According to the officials, the qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times higher than the baseline against all targeted HPV types and in all dose and age groups. Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age. The DCGI's approval had come following recommendation by the Subject Expert Committee (SEC) on COVID-19 of the CDSCO on Ju

DCGI approves India's first qHPV vaccine to treat cervical cancer

SII's CEO Adar Poonawalla tweeted to make the announcement, 'For the first time, there will be an Indian HPV vaccine to treat cervical cancer in women that is both affordable and accessible'

Serum Institute likely to launch cervical cancer vaccine in India in Nov

Country now depends on foreign companies and Serum's product is likely to bring down prices.

Why has the controversy around the HPV vaccine still not died down?

The HPV vaccine, administered to pre-pubescent girls to prevent cervical cancer, has received considerable bad press over its 14 years

Health guide: Here's all you need to know about cervical cancer

The leading cause of cervical cancer is HPV, found in about 99 per cent of cervical cancer cases

Pocket colposcope: New hope for India's teeming cervical cancer population

It's a cheap screening device that's gaining acceptance over the more intrusive speculum for its ability to capture cancerous and pre-cancerous conditions using high-quality pictures of the cervix